Daewoong Pharmaceutical Nears Completion of Phase 2 IPF Trial for Bersiporosin, Readout Set for H1 2027
Daewoong Pharmaceutical has completed patient enrollment for the global Phase 2 clinical trial of bersiporosin (DWN12088), its first-in-class...
Search results for "idiopathic"
Severe Lung Complications Drop Below 10% for Early Lung Cancer Patients with IPF Treated with Proton Therapy
For patients diagnosed with idiopathic pulmonary fibrosis —a chronic disease in which lung tissue inexplicably becomes scarred, stiffened, and...
AI Tracks Lung Scarring: 4-Percentage-Point Rise in One Year Signals Danger
Researchers have established an artificial intelligence benchmark to quantify the progression of idiopathic pulmonary...
Get Second and Third Opinions Before Spine Surgery, Urges Renowned Scoliosis Surgeon Kim Yong-jung
Dr. Kim Yong-jung, Director of the Spinal Deformity Center at Seoul Bumin Hospital, has performed approximately 2,400...
FDA Approves Celltrion’s Avtozma for Pediatric COVID-19 in High-Risk Patients
Celltrion announced on October 7 that the U.S. Food and Drug Administration has approved an expanded pediatric...
Celltrion Files for EU Approval of Cosentyx Biosimilar CT-P55, Targeting $6.7 Billion Autoimmune Market
Celltrion announced on the 24th that it has submitted a marketing authorization application to the European Medicines...
Hanmi’s 'Amoprel' Makes Global Waves: World’s First Ultra-Low Triple Hypertension Drug Lands in JACC
The Phase 3 clinical trial results for Hanmi Pharmaceutical’s Amoprel—the world’s first ultra-low-dose triple...
Busan Bumin Hospital’s Seok Sang-yoon Identifies Key Prognostic Factors for Degenerative Spinal Deformity Surgery in International Study
Seok Sang-yoon, Director of the Spine Center at Busan Bummin Hospital (Department of Orthopedic Surgery), has published...
1